Drug-induced liver injury: Mechanisms and test systems

Hepatology

Volumn 33, Issue 4, 2001, Pages 1009-1013

  Bissell, D Montgomery ^a   Gores, Gregory J ^b   Laskin, Debra L ^c   Hoofnagle, Jay H ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAYO CLINIC   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTECTION; CHOLESTASIS; CONFERENCE PAPER; DIAGNOSTIC TEST; DRUG INDUCED DISEASE; HUMAN; LIVER INJURY; LIVER SINUSOID; LIVER TOXICITY; PRIORITY JOURNAL;

EID: 0035088204     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.23505     Document Type: Article

References (44)

1. Troglitazone-induced fulminant hepatic failure
2. Evaluation of liver disease in the pediatric patient
3. Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration
4. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes
5. Subacute hepatic failure associated with a new antidiabetic agent, troglitazone: A case report with autopsy examination
6. Hepatocellular injury in a patient receiving rosiglitazone. A case report
7. Cytokine-mediated hepatic apoptosis
8. Depletion of hepatic glutathione prevents death receptor-dependent apoptotic and necrotic liver injury in mice
9. Metabolic depletion of ATP by fructose inversely controls CD95- and tumor necrosis factor receptor 1-mediated hepatic apoptosis
10. Intracellular signaling in response to toxic liver injury
11. Modulation of tolerance by mutant heat shock transcription factors
12. Twenty years of biochemistry of human P450s: Purification, expression, mechanism, and relevance to drugs
13. Humanized xenobiotic response in mice expressing nuclear receptor SXR
14. The use of single-nucleotide polymorphism maps in pharmacogenomics
15. Glucuronidation in humans. Pharmacogenetic and developmental aspects
16. Liver disease after human marrow transplantation
17. Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat
18. Glutathione defense in non-parenchymal cells
19. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease
20. Xenobiotic-induced inflammation and injury in the liver
21. 1, 2-Dichlorobenzene-mediated hepatocellular oxidative stress in Fischer-344 and Sprague-Dawley rats
22. Macrophages and inflammatory mediators in tissue injury
23. Drug-induced liver disease
24. Demonstration of a cellular immune response in halothane-exposed guinea pigs
25. Idiosyncratic drug reactions: The reactive metabolite syndromes
26. Molecular pathogenesis of cholestasis
27. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver
28. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
29. ATP depletion in rat cholangiocytes leads to marked internalization of membrane proteins
30. Acute carbon tetrachloride feeding induces damage of large but not small cholangiocytes from BDL rat liver
31. Mitochondria and childhood liver diseases
32. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
33. Amiodarone hepatotoxicity: Prevalence and clinico-pathologic correlations among 104 patients
34. Valproic acid hepatic fatalities. III. U.S. experience since 1986
35. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B
36. Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy
37. Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro
38. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabino furanosyl)-5-iodouracil in human liver cells
39. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity
40. Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration
41. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection
42. Depeletion of mitochondrial DNA, destruction of mitochondria, and accumulation of lipid droplets result from fialuridine treatment in woodchucks (Marmota monax)
43. Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria
44. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy